OPGN · OpGen Inc

-

Please sign in to comment on OPGN

1 Comment

Admin

4 years, 1 month ago

OpGen, Inc is currently in a long term downtrend where the price is trading 2.7% below its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.6.

OpGen, Inc's total revenue rose by 64.8% to $1M since the same quarter in the previous year.

Its net income has increased by 99.7% to $-7K since the same quarter in the previous year.

Finally, its free cash flow fell by 102.5% to $-7M since the same quarter in the previous year.

Based on the above factors, OpGen, Inc gets an overall score of 3/5.

Sector	Healthcare
Industry	Medical Devices
Exchange	PINK
CurrencyCode	USD
ISIN	US68373L3078

Market Cap	50M
PE Ratio	None
Beta	-1.61
Target Price	3
Dividend Yield	None

ABOUT

OpGen Inc

OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.

OPGN · OpGen Inc

-

OpGen Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest OpGen Inc using a moving average strategy